Intrinsiqs

Is Adaptive Biotechnologies Corporation overvalued?

Adaptive Biotechnologies Corporation (ADPT) — key valuation metrics and fundamentals.

No verdict
Price
$24.74
Fair value
Current P/E
Normal P/E
Market cap
$3.96B
Dividend yield
0.0%
Return on equity
-32.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ADPT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.